Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Apr-24 5:55 PM View:  | Tesi Raymond Joseph President and CEO Director 10% Owner | Inmune Bio, Inc. (INMB) | 19-Apr-24 | Grant | 18,028 | $8.32 | $149,993.00 | 1% 1.52M to 1.54M | 11% |
| 23-Apr-24 5:54 PM View: | Lowdell Mark William Chief Scientific Officer 10% Owner | Inmune Bio, Inc. (INMB) | 19-Apr-24 | Grant | 14,423 | $8.32 | $119,999.00 | < 1% 1.5M to 1.51M | 11% |
| 23-Apr-24 5:54 PM View: | Moss David J CFO, Treasurer & Secretary 10% Owner | Inmune Bio, Inc. (INMB) | 19-Apr-24 | Grant | 18,028 | $8.32 | $149,993.00 | 1% 1.25M to 1.27M | 11% |
| 23-Apr-24 5:53 PM View: | Juda Scott Director | Inmune Bio, Inc. (INMB) | 19-Apr-24 | Grant | 29,603 | $8.32 | $246,297.00 | 80% 37.0K to 66.6K | 11% |
| 13-Nov-23 11:31 AM View: | Juda Scott Director | Inmune Bio, Inc. (INMB) | 10-Nov-23 | Private Purchase | 7,000 | $6.95 | $48,650.00 | 23% 30.0K to 37.0K | |
| 14-Jul-23 4:05 PM View: | Schroeder Timothy J Director | Inmune Bio, Inc. (INMB) | 12-Jul-23 | Private Sale (Planned) | 10,000 | $11.01 | $110,085.00 | (11%) 92.19K to 82.19K | |
| 20-Mar-23 8:02 AM View: | Moss David J CFO, Treasurer & Secretary 10% Owner | Inmune Bio, Inc. (INMB) | 17-Mar-23 | Private Purchase | 2,500 | $6.43 | $16,062.50 | < 1% 1.25M to 1.25M | |
| 31-May-22 6:08 AM View: | Moss David J CFO, Treasurer & Secretary 10% Owner | Inmune Bio, Inc. (INMB) | 27-May-22 | Purchase | 3,000 | $6.79 | $20,370.00 | < 1% 1.24M to 1.25M | |
| 31-May-22 6:10 AM View: | Tesi Raymond Joseph President and CEO Director 10% Owner | Inmune Bio, Inc. (INMB) | 26-May-22 | Private Purchase | 6,300 | $6.41 | $40,383.00 | < 1% 1.51M to 1.52M | |
| 31-May-22 6:08 AM View: | Moss David J CFO, Treasurer & Secretary 10% Owner | Inmune Bio, Inc. (INMB) | 26-May-22 | Private Purchase | 7,700 | $6.27 | $48,279.00 | < 1% 1.24M to 1.24M | |
| 23-Mar-22 4:33 PM View: | Tesi Raymond Joseph President and CEO Director 10% Owner | Inmune Bio, Inc. (INMB) | 22-Mar-22 | Grant | 23,724 | $8.43 | $199,993.00 | 2% 1.49M to 1.51M | 9% |
| 23-Mar-22 4:29 PM View: | Ganjei James Kelly Director | Inmune Bio, Inc. (INMB) | 22-Mar-22 | Grant | 17,793 | $8.43 | $149,995.00 | 100% 0 to 17.79K | 9% |
| 23-Mar-22 4:35 PM View: | Lowdell Mark William Chief Scientific Officer 10% Owner | Inmune Bio, Inc. (INMB) | 22-Mar-22 | Grant | 23,590 | $8.43 | $198,864.00 | 2% 1.47M to 1.5M | 9% |
| 23-Mar-22 4:30 PM View: | Moss David J CFO, Treasurer & Secretary 10% Owner | Inmune Bio, Inc. (INMB) | 22-Mar-22 | Grant | 17,793 | $8.43 | $149,995.00 | 1% 1.22M to 1.24M | 9% |
| 17-Nov-21 6:10 PM View: | Juda Scott Director | Inmune Bio, Inc. (INMB) | 17-Nov-21 | Market Purchase | 2,500 | $13.55 | $33,875.00 | 9% 27.5K to 30.0K | 1% |
| 04-Nov-21 4:00 PM View: | Tesi Raymond Joseph President and CEO Director 10% Owner | Inmune Bio, Inc. (INMB) | 03-Nov-21 | Market Sale (Planned) | 3,626 | $20.00 | $72,520.00 | (< 1%) 1.49M to 1.49M | 2% |
| 04-Nov-21 4:00 PM View: | Moss David J CFO, Treasurer & Secretary 10% Owner | Inmune Bio, Inc. (INMB) | 03-Nov-21 | Market Sale (Planned) | 1,025 | $20.00 | $20,500.00 | (< 1%) 1.22M to 1.22M | 2% |
| 04-Nov-21 4:00 PM View: | Lowdell Mark William Chief Scientific Officer 10% Owner | Inmune Bio, Inc. (INMB) | 03-Nov-21 | Market Sale (Planned) | 701 | $20.00 | $14,020.00 | (< 1%) 1.47M to 1.47M | 2% |
| 29-Oct-21 4:01 PM View: | Moss David J CFO, Treasurer & Secretary 10% Owner | Inmune Bio, Inc. (INMB) | 27-Oct-21 | Market Sale (Planned) | 2,079 | $20.00 | $41,580.00 | (< 1%) 1.22M to 1.22M | 6% |
| 29-Oct-21 4:03 PM View: | Lowdell Mark William Chief Scientific Officer 10% Owner | Inmune Bio, Inc. (INMB) | 27-Oct-21 | Market Sale (Planned) | 2,357 | $20.00 | $47,140.00 | (< 1%) 1.48M to 1.47M | 6% |
| 29-Oct-21 4:03 PM View: | Tesi Raymond Joseph President and CEO Director 10% Owner | Inmune Bio, Inc. (INMB) | 27-Oct-21 | Market Sale (Planned) | 6,517 | $20.00 | $130,340.00 | (< 1%) 1.5M to 1.49M | 6% |
| 26-Oct-21 4:31 PM View: | Moss David J CFO, Treasurer & Secretary 10% Owner | Inmune Bio, Inc. (INMB) | 25-Oct-21 | Market Sale (Planned) | 13 | $20.00 | $260.00 | (< 1%) 1.22M to 1.22M | < 1% |
| 26-Oct-21 4:31 PM View: | Moss David J CFO, Treasurer & Secretary 10% Owner | Inmune Bio, Inc. (INMB) | 22-Oct-21 | Market Sale (Planned) | 1,142 | $20.00 | $22,840.00 | (< 1%) 1.22M to 1.22M | < 1% |
| 26-Oct-21 4:31 PM View: | Tesi Raymond Joseph President and CEO Director 10% Owner | Inmune Bio, Inc. (INMB) | 22-Oct-21 | Market Sale (Planned) | 23,616 | $20.00 | $472,320.00 | (2%) 1.52M to 1.5M | < 1% |
| 26-Oct-21 4:31 PM View: | Lowdell Mark William Chief Scientific Officer 10% Owner | Inmune Bio, Inc. (INMB) | 22-Oct-21 | Market Sale (Planned) | 400 | $20.00 | $8,000.00 | (< 1%) 1.48M to 1.48M | < 1% |
| 08-Sep-21 4:15 PM View: | Xencor Inc 10% Owner | Inmune Bio, Inc. (INMB) | 03-Sep-21 | Option Exercise | 108,000 | $7.80 | $842,400.00 | 6% 1.78M to 1.89M | |
| 19-Jul-21 7:39 PM View: | Moss David J CFO, Treasurer & Secretary 10% Owner | Inmune Bio, Inc. (INMB) | 16-Jul-21 | Option Exercise | 25,000 | $3.91 | $97,750.00 | 2% 1.2M to 1.22M | |
| 14-Jul-21 4:07 PM View: | Schroeder Timothy J Director | Inmune Bio, Inc. (INMB) | 13-Jul-21 | Market Sale (Planned) | 14,480 | $27.63 | $400,082.00 | (14%) 106.67K to 92.19K | 3% |
| 09-Jul-21 4:06 PM View: | Lowdell Mark William Chief Scientific Officer | Inmune Bio, Inc. (INMB) | 08-Jul-21 | Market Sale (Planned) | 24,150 | $20.19 | $487,588.00 | (2%) 1.5M to 1.48M | (< 1%) |
| 09-Jul-21 4:06 PM View: | Tesi Raymond Joseph President and CEO Director | Inmune Bio, Inc. (INMB) | 08-Jul-21 | Market Sale (Planned) | 24,351 | $20.08 | $488,968.00 | (2%) 1.54M to 1.51M | (< 1%) |
| 09-Jul-21 4:06 PM View: | Moss David J CFO, Treasurer & Secretary | Inmune Bio, Inc. (INMB) | 08-Jul-21 | Market Sale (Planned) | 16,302 | $20.09 | $327,492.00 | (1%) 1.21M to 1.2M | (< 1%) |
| 09-Jul-21 4:06 PM View: | Lowdell Mark William Chief Scientific Officer | Inmune Bio, Inc. (INMB) | 07-Jul-21 | Market Sale (Planned) | 5,850 | $20.02 | $117,117.00 | (< 1%) 1.51M to 1.5M | (1%) |
| 09-Jul-21 4:06 PM View: | Tesi Raymond Joseph President and CEO Director | Inmune Bio, Inc. (INMB) | 07-Jul-21 | Market Sale (Planned) | 5,649 | $20.02 | $113,082.00 | (< 1%) 1.54M to 1.54M | (1%) |
| 09-Jul-21 4:06 PM View: | Moss David J CFO, Treasurer & Secretary | Inmune Bio, Inc. (INMB) | 07-Jul-21 | Market Sale (Planned) | 8,698 | $20.01 | $174,030.00 | (< 1%) 1.22M to 1.21M | (1%) |
| 15-Jun-21 4:09 PM View: | Schroeder Timothy J Director | Inmune Bio, Inc. (INMB) | 14-Jun-21 | Market Sale (Planned) | 10,000 | $19.02 | $190,200.00 | (7%) 146.67K to 136.67K | 2% |
| 14-Jun-21 4:22 PM View: | Schroeder Timothy J Director | Inmune Bio, Inc. (INMB) | 10-Jun-21 | Market Sale (Planned) | 10,000 | $17.01 | $170,054.00 | (6%) 156.67K to 146.67K | (5%) |
| 01-Apr-21 4:31 PM View: | Schroeder Timothy J Director | Inmune Bio, Inc. (INMB) | 31-Mar-21 | Market Sale | 10,000 | $11.95 | $119,496.00 | (6%) 166.67K to 156.67K | < 1% |
| 29-Jan-20 8:39 PM View: | Powers Linda F 10% Owner | Inmune Bio, Inc. (INMB) | 27-Jan-20 | Market Sale | 220,000 | $4.60 | $1,012,000.00 | (19%) 1.13M to 910.0K | (178%) |
| 12-Sep-19 9:15 PM View: | Lowdell Mark William Chief Scientific Officer 10% Owner | Inmune Bio, Inc. (INMB) | 11-Sep-19 | Market Purchase | 2,918 | $6.23 | $18,178.60 | < 1% 1.5M to 1.51M | 106% |
| 22-Aug-19 4:30 PM View: | Juda Scott Director | Inmune Bio, Inc. (INMB) | 21-Aug-19 | Market Purchase | 2,500 | $6.00 | $15,000.00 | 10% 25.0K to 27.5K | 114% |
| 22-Aug-19 4:30 PM View: | Juda Scott Director | Inmune Bio, Inc. (INMB) | 20-Aug-19 | Market Purchase | 2,500 | $6.00 | $15,000.00 | 11% 22.5K to 25.0K | 114% |
| 21-Aug-19 4:33 PM View: | Tesi Raymond Joseph President & CEO Director 10% Owner | Inmune Bio, Inc. (INMB) | 20-Aug-19 | Market Purchase | 2,000 | $5.99 | $11,987.20 | < 1% 1.54M to 1.54M | 114% |
| 21-Aug-19 4:34 PM View: | Moss David J CFO, Treasurer & Secretary 10% Owner | Inmune Bio, Inc. (INMB) | 20-Aug-19 | Market Purchase | 3,000 | $5.65 | $16,950.00 | < 1% 1.22M to 1.22M | 127% |
| 12-Aug-19 5:34 PM View: | Tesi Raymond Joseph President & CEO Director 10% Owner | Inmune Bio, Inc. (INMB) | 09-Aug-19 | Market Purchase | 2,000 | $7.03 | $14,058.30 | < 1% 1.54M to 1.54M | 82% |
| 04-Jun-19 4:35 PM View: | Moss David J CFO, Treasurer & Secretary 10% Owner | Inmune Bio, Inc. (INMB) | 03-Jun-19 | Private Purchase | 10,000 | $6.00 | $60,000.00 | < 1% 1.21M to 1.22M | |
| 04-Jun-19 4:39 PM View: | Juda Scott Director | Inmune Bio, Inc. (INMB) | 03-Jun-19 | Private Purchase | 10,000 | $6.00 | $60,000.00 | 80% 12.5K to 22.5K | |
| 04-Jun-19 4:33 PM View: | Tesi Raymond Joseph President & CEO Director 10% Owner | Inmune Bio, Inc. (INMB) | 03-Jun-19 | Private Purchase | 10,000 | $6.00 | $60,000.00 | < 1% 1.53M to 1.54M | |
| 05-Jun-19 4:31 PM View: | Powers Linda F 10% Owner | Inmune Bio, Inc. (INMB) | 03-Jun-19 | Private Purchase | 10,000 | $6.00 | $60,000.00 | < 1% 1.12M to 1.13M | |
| 10-May-19 9:21 PM View: | Powers Linda F 10% Owner | Inmune Bio, Inc. (INMB) | 08-May-19 | Private Purchase | 61,667 | $9.00 | $555,003.00 | 6% 1.06M to 1.12M | |
| 07-May-19 4:08 PM View: | Moss David J CFO, Treasurer & Secretary 10% Owner | Inmune Bio, Inc. (INMB) | 06-May-19 | Private Purchase | 5,000 | $9.00 | $45,000.00 | < 1% 1.21M to 1.21M |
